Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,743,312
+$55,986 QoQ
Shares Held
162,424
-20.1% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $27,399,554 across 15 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
162,424 | $5,743,312 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
8,887 | $5,269,813 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
36,232 | $4,773,203 | |
| 4 | ZTS |
Zoetis Inc.
|
33,846 | $4,000,935 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
354,260 | $3,372,555 | |
| 6 | VTRS |
Viatris Inc
|
99,502 | $1,344,272 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
216,623 | $760,346 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
85,199 | $707,151 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,743,312 | 162,424 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,687,326 | 203,264 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,397,060 | 179,902 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,614,363 | 161,285 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,967,792 | 150,448 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,027,520 | 209,580 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,150,241 | 255,457 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,952,199 | 288,473 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,487,067 | 313,523 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,630,689 | 347,177 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,642,345 | 308,545 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,350,589 | 266,792 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,207,280 | 255,668 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,571,110 | 328,018 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,489,790 | 290,631 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,185,912 | 140,514 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,815,667 | 221,044 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,678,300 | 244,123 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,148,640 | 102,096 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,555,351 | 104,215 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,204,815 | 171,564 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $873,131 | 43,766 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $1,133,214 | 58,383 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $244,260 | 16,939 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||